| Withdrawn | A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB) NCT04138875 | Yale University | Phase 2 |
| Completed | Positive Psychology Intervention In HSCT NCT05147311 | Brigham and Women's Hospital | N/A |
| Active Not Recruiting | First-in-Human Study of ICT01 in Patients With Advanced Cancer NCT04243499 | ImCheck Therapeutics | Phase 1 / Phase 2 |
| Completed | Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families NCT04172818 | Centre Hospitalier Universitaire, Amiens | N/A |
| Unknown | Hematopoietic Stem Cell Transplantation and Childhood Leukemia Quality of Life in SIbling DONors NCT03659071 | Assistance Publique Hopitaux De Marseille | N/A |
| Completed | A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients NCT03654404 | Brigham and Women's Hospital | N/A |
| Terminated | Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Speci NCT03126864 | M.D. Anderson Cancer Center | Phase 1 |
| Unknown | Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 an NCT03185494 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Terminated | Ibrutinib, Nivolumab and Blinatumomab in Richter Transformation NCT03121534 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 an NCT03097770 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Unknown | Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma NCT03110640 | First Affiliated Hospital of Wenzhou Medical University | Phase 1 |
| Unknown | Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy NCT02903810 | Xuzhou Medical University | Phase 1 / Phase 2 |
| Unknown | Competitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/Lymphoma NCT02685670 | The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine | Phase 1 / Phase 2 |
| Completed | Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases NCT02248597 | Wake Forest University Health Sciences | Phase 2 |
| Withdrawn | Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease NCT01988701 | Ohio State University Comprehensive Cancer Center | — |
| Completed | Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patien NCT02116530 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Unknown | CART-19 Immunotherapy in Mantle Cell Lymphoma NCT02081937 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Completed | Improved Outcome in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Patients by Reducing Caregiver Distre NCT02037568 | University of Colorado, Denver | N/A |
| Completed | Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploident NCT01982682 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Withdrawn | Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies NCT01620229 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Quality of Life in Caregivers of Hospitalized Older Patients With Cancer NCT01866969 | City of Hope Medical Center | N/A |
| Completed | Supportive Care for Patients With Hematological Malignancies Undergoing Hematopoietic Cell Transplant NCT01758484 | Fred Hutchinson Cancer Center | N/A |
| Unknown | Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by CART19 NCT01864889 | Chinese PLA General Hospital | N/A |
| Unknown | Genetically Engineered Lymphocyte Therapy in Treating Patients With Lymphoma That is Resistant or Refractory t NCT01735604 | Chinese PLA General Hospital | Phase 1 / Phase 2 |
| Withdrawn | Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant NCT01660347 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Completed | Effects of Healing Touch on Patients Undergoing Hematopoietic Stem Cell Transplant NCT02194413 | University of Iowa | N/A |
| Active Not Recruiting | Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic NCT01199562 | City of Hope Medical Center | — |
| Completed | Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic NCT01212380 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Completed | CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy NCT01029366 | University of Pennsylvania | Phase 1 |
| Unknown | Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiatio NCT00959231 | Cancer Research UK | Phase 2 |
| Completed | Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT) NCT00833898 | University of Colorado, Denver | Phase 3 |
| Completed | Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregive NCT00896792 | Mayo Clinic | EARLY_Phase 1 |
| Withdrawn | Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain NCT00737191 | Mayo Clinic | N/A |
| Completed | Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy NCT00670917 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Completed | Study of Physical and Mental Health of Older Patients With Newly Diagnosed Cancer NCT00769951 | Case Comprehensive Cancer Center | — |
| Unknown | Screening to Predict Weight Loss in Patients With Cancer NCT00710632 | Queen's Medical Center | N/A |
| Completed | Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem NCT00489203 | Fred Hutchinson Cancer Center | Phase 2 |
| Withdrawn | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer NCT00899808 | Rutgers, The State University of New Jersey | — |
| Terminated | Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas NCT00089089 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Tran NCT01056614 | Fred Hutchinson Cancer Center | Phase 2 |
| Terminated | Alvocidib in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignan NCT00070239 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Bortezomib and Fludarabine With or Without Rituximab in Treating Patients With Relapsed or Refractory Indolent NCT00068315 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer NCT00049504 | Fred Hutchinson Cancer Center | Phase 2 |
| No Longer Available | Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts. NCT02158767 | Leland Metheny | — |